Global Spread of Carbapenemase-producing Enterobacteriaceae

These resistance traits have been identified among nosocomial and community-acquired infections.

[1]  Y. Carmeli,et al.  First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States , 2008, Antimicrobial Agents and Chemotherapy.

[2]  P. Nordmann,et al.  Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands. , 2011, Journal of medical microbiology.

[3]  G. Araj,et al.  First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco , 2010, Annals of tropical medicine and parasitology.

[4]  D. Livermore,et al.  Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. , 2011, The Lancet. Infectious diseases.

[5]  M. Falagas,et al.  Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. , 2011, Future microbiology.

[6]  A. Seck,et al.  Class D OXA-48 Carbapenemase in Multidrug-Resistant Enterobacteria, Senegal , 2011, Emerging infectious diseases.

[7]  P. Nordmann,et al.  Global spread of New Delhi metallo-β-lactamase 1. , 2010, The Lancet. Infectious diseases.

[8]  Y. Carmeli,et al.  Laboratory and Clinical Evaluation of Screening Agar Plates for Detection of Carbapenem-Resistant Enterobacteriaceae from Surveillance Rectal Swabs , 2011, Journal of Clinical Microbiology.

[9]  P. Nordmann,et al.  Use of ChromID Extended-Spectrum β-Lactamase Medium for Detecting Carbapenemase-Producing Enterobacteriaceae , 2010, Journal of Clinical Microbiology.

[10]  P. Nordmann,et al.  Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. , 2011, The Journal of antimicrobial chemotherapy.

[11]  Yehuda Carmeli,et al.  Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality , 2007, Antimicrobial Agents and Chemotherapy.

[12]  V. Miriagou,et al.  Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  D. Plachouras,et al.  Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae. , 2008, The Journal of antimicrobial chemotherapy.

[14]  Ronald N. Jones,et al.  Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 , 2010, Antimicrobial Agents and Chemotherapy.

[15]  P. Nordmann,et al.  How To Detect NDM-1 Producers , 2010, Journal of Clinical Microbiology.

[16]  Kenneth S. Thomson,et al.  Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues , 2010, Journal of Clinical Microbiology.

[17]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[18]  J. Quinn,et al.  Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase blaKPC-2 Gene , 2010, Emerging infectious diseases.

[19]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[20]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[21]  P. Nordmann,et al.  Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases , 2011, Journal of Clinical Microbiology.

[22]  M. Toleman,et al.  Global spread of New Delhi metallo-β-lactamase 1. , 2010, The Lancet. Infectious diseases.

[23]  N. Woodford,et al.  Redefining extended-spectrum beta-lactamases: balancing science and clinical need. , 2008, The Journal of antimicrobial chemotherapy.

[24]  A. Fluit,et al.  Global spread of New Delhi metallo-β-lactamase 1. , 2010, The Lancet. Infectious diseases.

[25]  P. Nordmann,et al.  Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in France , 2011, Antimicrobial Agents and Chemotherapy.

[26]  P. Nordmann,et al.  Spread of OXA-48-Encoding Plasmid in Turkey and Beyond , 2010, Antimicrobial Agents and Chemotherapy.

[27]  F. Baquero,et al.  Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15 , 2008, Emerging infectious diseases.

[28]  P. Nordmann,et al.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.

[29]  P. Nordmann,et al.  Multiplex PCR for detection of acquired carbapenemase genes. , 2011, Diagnostic microbiology and infectious disease.

[30]  Y. Arakawa,et al.  Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens , 1995, Antimicrobial agents and chemotherapy.

[31]  P. Nordmann,et al.  Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.

[33]  Iraida E. Robledo,et al.  Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. , 2009, MMWR. Morbidity and mortality weekly report.

[34]  P. Nordmann,et al.  Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? , 2011, The Journal of antimicrobial chemotherapy.

[35]  C. Bamia,et al.  Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections , 2009, Antimicrobial Agents and Chemotherapy.

[36]  Gopi Patel,et al.  Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies , 2008, Infection Control & Hospital Epidemiology.

[37]  P. Hsueh,et al.  High burden of antimicrobial resistance in Asia. , 2011, International journal of antimicrobial agents.

[38]  P. Nordmann,et al.  Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.

[39]  Timothy R. Walsh,et al.  Metallo-β-Lactamases: the Quiet before the Storm? , 2005, Clinical Microbiology Reviews.

[40]  K. Riesenberg,et al.  Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia , 2009, Infection Control & Hospital Epidemiology.